Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M

Benzinga Newsdesk www.benzinga.com Negative 58.0%

Neg 58% Neu 0% Pos 0%

Sanara MedTech (NASDAQ:SMTI) affirms FY2026 sales outlook from $116.000 million-$121.000 million to $116.000 million-$121.000 million.